See more : PT Bank Artha Graha Internasional Tbk (INPC.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Novavax, Inc. (NVV1.F) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Novavax, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Plateau Mineral Development, Inc. (PMDP) Income Statement Analysis – Financial Results
- AEON Mall Co., Ltd. (AMLLF) Income Statement Analysis – Financial Results
- China Evergrande Group (EV1.F) Income Statement Analysis – Financial Results
- Argus (Shanghai) Textile Chemicals Co.,Ltd. (603790.SS) Income Statement Analysis – Financial Results
- China Film Co.,Ltd. (600977.SS) Income Statement Analysis – Financial Results
Novavax, Inc. (NVV1.F)
About Novavax, Inc.
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 556.38M | 1.60B | 1.15B | 475.60M | 18.66M | 34.29M | 31.18M | 15.35M | 36.25M | 30.66M | 20.92M | 22.08M | 14.69M | 343.00K | 325.00K | 1.06M | 1.51M | 4.68M | 7.39M | 8.26M | 11.79M | 15.01M | 24.07M | 2.48M | 1.20M | 700.00K | 500.00K | 100.00K |
| Cost of Revenue | 343.77M | 902.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 237.94M | 162.64M | 14.99M | 8.22M | 14.69M | 7.00M | 0.00 | 0.00 | 0.00 | 221.00K | 6.47M | 5.79M | 3.49M | 2.06M | 3.56M | 4.05M | -594.00K | -400.00K | -300.00K | -300.00K | -300.00K |
| Gross Profit | 212.61M | 696.31M | 1.15B | 475.60M | 18.66M | 34.29M | 31.18M | -222.59M | -126.39M | 15.67M | 12.69M | 7.38M | 7.69M | 343.00K | 325.00K | 1.06M | 1.29M | -1.79M | 1.60M | 4.77M | 9.73M | 11.45M | 20.01M | 3.07M | 1.60M | 1.00M | 800.00K | 400.00K |
| Gross Profit Ratio | 38.21% | 43.55% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | -1,449.79% | -348.67% | 51.12% | 60.69% | 33.45% | 52.32% | 100.00% | 100.00% | 100.00% | 85.39% | -38.22% | 21.62% | 57.75% | 82.55% | 76.28% | 83.16% | 124.00% | 133.33% | 142.86% | 160.00% | 400.00% |
| Research & Development | 737.50M | 1.24B | 2.53B | 747.03M | 113.84M | 173.80M | 168.44M | 237.94M | 162.64M | 79.44M | 50.31M | 26.06M | 17.89M | 28.03M | 25.78M | 24.33M | 17.60M | 11.53M | 5.08M | 7.37M | 10.06M | 11.50M | 10.78M | 9.36M | 3.40M | 3.40M | 2.90M | 3.70M |
| General & Administrative | 0.00 | 488.69M | 298.36M | 145.29M | 34.42M | 34.41M | 34.45M | 46.53M | 30.84M | 19.93M | 14.82M | 10.99M | 0.00 | 10.81M | 11.93M | 11.09M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 468.95M | 488.69M | 298.36M | 145.29M | 34.42M | 34.41M | 34.45M | 46.53M | 30.84M | 19.93M | 14.82M | 10.99M | 11.38M | 10.81M | 11.93M | 11.09M | 13.96M | 11.29M | 16.66M | 33.03M | 15.72M | 21.50M | 18.49M | 5.86M | 2.40M | 2.50M | 2.40M | 1.90M |
| Other Expenses | -427.32M | -382.92M | -8.20M | 12.59M | -13.00K | 108.00K | 67.00K | -31.00K | -120.00K | 0.00 | 182.00K | 45.00K | 11.38M | 0.00 | 0.00 | 0.00 | 13.96M | 11.29M | 5.69M | 21.87M | 15.72M | 21.50M | 18.49M | 6.45M | 2.80M | 2.80M | 2.70M | 2.20M |
| Operating Expenses | 779.13M | 1.34B | 2.83B | 892.32M | 148.26M | 208.21M | 202.89M | 284.47M | 193.49M | 99.36M | 65.13M | 37.05M | 29.26M | 38.84M | 37.71M | 35.42M | 31.56M | 22.82M | 10.77M | 29.23M | 25.78M | 33.00M | 29.27M | 15.81M | 6.20M | 6.20M | 5.60M | 5.90M |
| Cost & Expenses | 1.12B | 2.24B | 2.83B | 892.32M | 148.26M | 208.21M | 202.89M | 284.47M | 193.49M | 114.35M | 73.35M | 51.74M | 36.27M | 38.84M | 37.71M | 35.42M | 31.78M | 29.29M | 16.56M | 32.72M | 27.84M | 36.56M | 33.32M | 15.22M | 5.80M | 5.90M | 5.30M | 5.60M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | -1.42M | -1.42M | 1.95M | 0.00 | 660.00K | 286.00K | 187.00K | 165.00K | 136.00K | 189.00K | 285.00K | 959.00K | 3.29M | 1.54M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 551.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.42M | 19.88M | 21.13M | 15.15M | 12.19M | 12.19M | 14.07M | 12.97M | 241.00K | 157.00K | 160.00K | 32.00K | 9.00K | 9.00K | 501.00K | 1.68M | 1.61M | 0.00 | 2.00M | 1.53M | 1.22M | 1.14M | 490.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 41.23M | 29.05M | 12.66M | 4.89M | -18.03M | 8.16M | 9.82M | 8.51M | 5.98M | 4.42M | 2.59M | 1.67M | 1.61M | 1.37M | 1.19M | 893.00K | -1.01M | 2.72M | 3.48M | 3.05M | 1.19M | 1.14M | 3.49M | 594.00K | 400.00K | 300.00K | 300.00K | 300.00K |
| EBITDA | -487.39M | -633.77M | -1.68B | -416.72M | -114.83M | -164.40M | -159.88M | -258.50M | -150.71M | -78.37M | -49.21M | -27.79M | -19.83M | -34.78M | -36.89M | -33.47M | -30.27M | -20.75M | -2.53M | -21.41M | -14.87M | -20.42M | -5.77M | -12.15M | -4.20M | -4.90M | -4.50M | -5.20M |
| EBITDA Ratio | -87.60% | -39.64% | -147.13% | -87.62% | -742.76% | -507.23% | -550.78% | -1,752.84% | -433.75% | -274.98% | -236.55% | -125.88% | -135.01% | -10,280.47% | -11,351.69% | -3,029.04% | -2,000.73% | -467.48% | -225.51% | -395.19% | -126.16% | -136.09% | -23.96% | -490.83% | -350.00% | -742.86% | -940.00% | -5,300.00% |
| Operating Income | -566.51M | -644.74M | -1.69B | -416.72M | -120.58M | -173.92M | -171.71M | -269.11M | -157.24M | -83.69M | -52.43M | -29.67M | -21.58M | -38.49M | -37.38M | -34.36M | -30.27M | -24.61M | -9.17M | -24.46M | -16.05M | -21.56M | -9.26M | -12.74M | -4.60M | -5.20M | -4.80M | -5.50M |
| Operating Income Ratio | -101.82% | -40.32% | -147.13% | -87.62% | -646.13% | -507.23% | -550.78% | -1,752.84% | -433.75% | -272.97% | -250.70% | -134.38% | -146.92% | -11,222.74% | -11,502.46% | -3,229.32% | -2,000.73% | -525.45% | -124.13% | -296.17% | -136.22% | -143.67% | -38.46% | -514.83% | -383.33% | -742.86% | -960.00% | -5,500.00% |
| Total Other Income/Expenses | 23.48M | -8.91M | -27.96M | -1.54M | -12.11M | -10.83M | -12.06M | -10.85M | 299.00K | 744.00K | 476.00K | 1.16M | 2.63M | 2.34M | -2.96M | 8.23M | 0.00 | 7.11M | -302.10K | 5.39M | 0.00 | 0.00 | -490.00K | 0.00 | 0.00 | 300.00K | 200.00K | 100.00K |
| Income Before Tax | -543.03M | -610.74M | -1.51B | -341.84M | -118.21M | -161.61M | -153.04M | -265.43M | -144.47M | -68.55M | -37.71M | -21.62M | -14.60M | -26.95M | -26.75M | -26.13M | -19.55M | -17.49M | -9.47M | -19.07M | 0.00 | 0.00 | -9.75M | 0.00 | 0.00 | -4.90M | -4.60M | -5.40M |
| Income Before Tax Ratio | -97.60% | -38.20% | -131.59% | -71.88% | -633.44% | -471.34% | -589.46% | -1,823.53% | -432.93% | -270.55% | -248.42% | -129.13% | -129.03% | -10,541.69% | -11,807.38% | -3,413.72% | -1,964.95% | -492.59% | -151.25% | -313.80% | 0.00% | 0.00% | -40.49% | 0.00% | 0.00% | -700.00% | -920.00% | -5,400.00% |
| Income Tax Expense | 2.03M | 4.01M | 25.70M | -81.30M | -14.48M | -20.36M | 0.00 | 0.00 | 0.00 | 0.00 | 18.14K | 0.00 | 317.37K | -335.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.22M | 1.14M | 0.00 | -551.00K | -100.00K | -400.00K | -300.00K | 100.00K |
| Net Income | -545.06M | -614.75M | -1.53B | -341.84M | -118.21M | -161.61M | -153.04M | -265.43M | -144.47M | -68.55M | -37.72M | -21.62M | -14.92M | -26.62M | -26.75M | -25.93M | -23.78M | -17.49M | -9.47M | -19.07M | -17.27M | -22.70M | -9.75M | -12.19M | -4.50M | -4.80M | -4.50M | -5.50M |
| Net Income Ratio | -97.97% | -38.45% | -133.83% | -71.88% | -633.44% | -471.34% | -589.46% | -1,823.53% | -432.93% | -270.55% | -248.54% | -129.13% | -131.84% | -10,410.50% | -11,807.38% | -3,388.06% | -2,389.35% | -492.59% | -151.25% | -313.80% | -146.57% | -151.26% | -40.49% | -492.57% | -375.00% | -685.71% | -900.00% | -5,500.00% |
| EPS | -5.41 | -7.86 | -20.62 | -5.94 | -4.91 | -8.74 | -10.49 | -19.53 | -11.05 | -6.12 | -4.50 | -3.34 | -2.62 | -5.07 | -6.27 | -7.63 | -7.80 | -5.92 | -4.41 | -10.30 | -11.57 | -18.58 | -8.60 | -12.82 | -6.20 | -7.72 | -7.71 | -10.86 |
| EPS Diluted | -5.41 | -7.86 | -20.62 | -5.94 | -4.91 | -8.74 | -10.49 | -19.53 | -11.05 | -6.12 | -4.50 | -3.34 | -2.62 | -5.07 | -6.27 | -7.63 | -7.80 | -5.92 | -4.41 | -10.30 | -11.57 | -18.58 | -8.60 | -12.82 | -6.20 | -7.72 | -7.71 | -10.86 |
| Weighted Avg Shares Out | 100.77M | 78.18M | 74.40M | 57.55M | 24.10M | 18.49M | 14.63M | 13.54M | 13.11M | 11.29M | 8.48M | 6.59M | 5.68M | 5.24M | 4.28M | 3.41M | 3.06M | 2.93M | 2.14M | 1.85M | 1.49M | 1.22M | 1.13M | 950.79K | 725.55K | 621.42K | 583.37K | 506.64K |
| Weighted Avg Shares Out (Dil) | 100.77M | 78.18M | 74.40M | 57.55M | 24.10M | 18.49M | 14.63M | 13.54M | 13.11M | 11.29M | 8.48M | 6.59M | 5.68M | 5.24M | 4.28M | 3.41M | 3.06M | 2.93M | 2.14M | 1.85M | 1.49M | 1.22M | 1.13M | 950.79K | 725.55K | 621.42K | 583.37K | 506.64K |
No news found for: NVV1.F
Source: https://incomestatements.info
Category: Stock Reports